Table 3

		Kidney transplanted patients: time after renal transplantation (Days)
		0	15	30	45	60	90	120	180	360
αβ T cells (cells/µL) ^a	CMV act	619±249^	1238±812	1131±628	1309±740	1285±601	1363±677	1332±724	1425±565	1509±712
αβ T cells (cells/µL) ^a	CMV neg	693±561^	1390±613	1445±580	1219±597	1246±530	1184±487	1263±568	1389±481	1290±504
αβ T cells (%) ^b	CMV act	94.4±2.4	93.8±2.8	95.8±3.0	94.4±3.0	94.0±3.0	92.7±3.8	92.5±5.1	92.6±4.6	92.0±8.4
αβ T cells (%) ^b	CMV neg	92.2±6.4	90.8±6.2	93.2±5.1	91.5±6.1	93.4±6.1	91.9±7.6	90.8±8.1	91.2±8.0	92.8±5.4

Means± SD. a absolute cell count/μL of blood; b results are expressed as % of CD3+ T cells;
^ = p<0.05 versus all the other observation times

Table 3: Total numbers and percentages of peripheral αβ T cells in kidney transplanted patients who experienced CMV activation (CMV-act) and patients who did not (CMV-neg) in the first year after renal transplantation.